Boston Scientific acquires Valencia Technologies, maker of eCoin overactive bladder device

Boston Scientific Corporation

Boston Scientific Corporation

BSX

0.00
  • Boston Scientific acquired Valencia Technologies, adding the eCoin System for minimally invasive tibial neurostimulation to treat urge urinary incontinence linked to overactive bladder.
  • The deal expands Boston Scientific’s urology portfolio alongside sacral neuromodulation therapies, broadening physician and patient treatment choices.
  • eCoin is implanted near the ankle in a procedure typically completed in about 20 minutes, positioned as a “set it and forget it” option.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boston Scientific Corporation published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.